As China cracks down on faked drug trial data, US FDA abandons disclosure rule
The FDA has walked away from a 2010 rule that would have forced drug makers to disclose fabricated data to regulators. As Bloomberg Law reported last week, the FDA has withdrawn the proposed rule, “Reporting Information Regarding Falsification of Data,” which would